Last $52.51 USD
Change Today -0.31 / -0.59%
Volume 2.2M
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for glaxosmithkline plc-spon adr (GSK)

GlaxoSmithKline plc may have more financial risk than other companies in the Pharmaceuticals industry. It remains one of the most highly leveraged, despite its Debt to Total Capital ratio shrinking to 70.02% over the last fiscal year. However, an examination of near-term assets and liabilities shows that, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 55.64 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 179.00 days.
View Balance Sheet In British Pound
Currency in
Millions of US Dollars
As of:Dec 31
Dec 31
Dec 31
Dec 31
4 Year
Cash and Equivalents10,171.99,595.97,026.49,293.6
Short-Term Investments309.0309.0136.0110.8
Trading Asset Securities156.2117.682.3260.3
TOTAL CASH AND SHORT TERM INVESTMENTS10,637.110,022.47,244.89,664.7
Accounts Receivable7,938.37,458.06,910.66,660.3
Notes Receivable84.068.967.262.1
Other Receivables1,367.01,407.31,519.82,146.2
TOTAL RECEIVABLES9,389.38,934.28,497.68,868.7
Prepaid Expenses429.9569.3476.9487.0
Other Current Assets30.21,120.1109.21.7
TOTAL CURRENT ASSETS26,930.227,150.222,993.825,571.6
Gross Property Plant and Equipment30,720.530,539.230,668.530,799.5
Accumulated Depreciation-15,530.7-15,848.1-15,930.4-15,900.2
NET PROPERTY PLANT AND EQUIPMENT15,189.814,691.014,738.114,899.3
Long-Term Investments3,172.32,074.02,384.72,562.7
Deferred Tax Assets, Long Term4,309.24,784.54,015.33,499.8
Other Intangibles14,328.313,102.417,064.015,589.5
Other Long-Term Assets933.7881.71,145.31,493.0
TOTAL ASSETS70,919.468,988.169,661.570,677.5
Accounts Payable3,595.54,312.64,477.24,599.8
Accrued Expenses4,616.64,668.66,574.76,932.4
Short-Term Borrowings419.8183.13,402.43,012.8
Current Portion of Long-Term Debt/Capital Lease68.94,347.92,695.41,671.0
Current Portion of Capital Lease Obligations53.757.145.345.3
Current Income Taxes Payable1,758.32,759.22,307.42,438.4
Other Current Liabilities, Total10,909.18,872.13,471.24,033.8
Unearned Revenue, Current117.663.8272.1280.5
TOTAL CURRENT LIABILITIES21,485.725,207.223,200.422,968.6
Long-Term Debt24,750.420,390.824,555.625,867.2
Capital Leases119.2102.482.389.0
Minority Interest1,440.91,335.11,573.61,368.7
Pension & Other Post-Retirement Benefits4,487.25,190.95,241.33,676.1
Deferred Tax Liability Non-Current1,187.31,380.41,686.11,163.8
Other Non-Current Liabilities2,524.11,892.63,582.13,793.7
TOTAL LIABILITIES54,554.054,164.458,347.757,558.4
Common Stock2,381.32,329.32,265.52,243.6
Additional Paid in Capital2,398.12,809.63,395.74,357.9
Retained Earnings5,827.43,897.8-342.6549.2
Comprehensive Income and Other4,317.64,452.04,421.84,599.8
TOTAL COMMON EQUITY14,924.513,488.69,740.311,750.5
TOTAL EQUITY16,365.414,823.711,313.813,119.2
TOTAL LIABILITIES AND EQUITY70,919.468,988.169,661.570,677.5

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:US $52.51 USD -0.31

GSK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €94.15 EUR +1.21
Gilead Sciences Inc $70.00 USD +0.72
L'Oreal SA €121.35 EUR -0.75
Novo Nordisk A/S kr235.60 DKK +4.90
Sanofi €75.48 EUR +0.71
View Industry Companies

Industry Analysis


Industry Average

Valuation GSK Industry Range
Price/Earnings 14.3x
Price/Sales 2.9x
Price/Book 10.8x
Price/Cash Flow 14.1x
TEV/Sales 2.9x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at